Rich Goldberg, M.D., director of the WVU Cancer Institute and Laurence S. and Jean J. DeLynn chair of Oncology, will step down from those positions and transition toward retirement once an interim is named or at the end of the calendar year.
The recruitment process for a successor will begin in the next several weeks and take place in conjunction with an executive search firm.
Dr. Goldberg’s 35-year academic career encompassed caring for thousands of patients, educating trainees and physicians from around the world, conducting research, and managing the Cancer Institute.
Following his retirement, he plans to continue to play a supportive role in mentoring faculty and serving as a resource to the Cancer Institute’s leadership. He and his wife, Lynda, expect to continue to reside in Morgantown.
A formal celebration of Goldberg’s accomplishments and services will be scheduled at a later date and communicated through internal news channels.
“Vaporized: America’s E-Cigarette Addiction,” a comprehensive look inside the rapidly growing and highly controversial vaping industry, a market expected to hit $9 billion by the end of 2019.
The Department of Diagnostic Sciences has developed a team of specialists aimed at raising awareness about oral cancer. The efforts include educating the public about the causes of oral cancer while promoting prevention and regular oral exams. In addition, the team maintains an active biopsy service staffed by pathologists trained specifically in the diagnosis of tumors of the mouth.
Some cancers are difficult to treat due to where they appear in the body. For some abdominal cancers, intravenous chemotherapy may not work because drugs flowing through the whole body don’t penetrate into the peritoneal cavity – the space surrounding your abdominal organs.